Table 3.
Effect of flaxseed oil supplementation on AEA status
| Variable | Flaxseed oil (n = 21) | Placebo (n = 19) | MD (95% CI), P value |
|---|---|---|---|
| AEA (ng/ml) | |||
| Before | 5.45 (2.98) | 6.76 (2.72) | 1.31 (− 0.54 to 3.17), 0.158a |
| After | 4.73 (2.67) | 6.44 (2.44) | 0.64 (0.12 to 1.15), 0.016b |
| MD (95% CI), P valuec | − 0.71 (− 1.08 to − 0.34), 0.001 | − 0.32 (− 0.70 to 0.05), 0.091 | |
Values are expressed as mean (SD)
AEA N-arachidonoyl ethanolamine, MD mean difference
aIndependent samples t-test
bAdjusted for baseline values, weight differences, energy intake changes and fat intake changes using the analysis of covariance (ANCOVA) test
cPaired-samples t-test